4.6 Article

Distinct responses of human peripheral blood cells to different misfolded protein oligomers

Journal

IMMUNOLOGY
Volume 164, Issue 2, Pages 358-371

Publisher

WILEY
DOI: 10.1111/imm.13377

Keywords

immunoregulation; neurodegeneration; peripheral immunity; protein misfolding diseases; Th1; Th17; Tregs

Categories

Funding

  1. Spanish Ministry of Economy [RTI2018-098432-B-I00]
  2. Regional Ministry of Economy [PAIDI2020 CTS-677]
  3. Fundacion `Ramon Areces'
  4. Andalusian Regional Government-FEDER [US-1265227]
  5. Programa `Ramon y Cajal' of the Spanish Ministry of Economy [RYC-2017-23127]
  6. FEBS (Short-Term Fellowship)
  7. EMBO [ASTF 450-2013]
  8. Italian Society of Biochemistry and Molecular Biology
  9. Cambridge Centre for Misfolding Diseases, UK

Ask authors/readers for more resources

Recent studies show that different types of protein misfolded oligomers have varying effects on the peripheral immune system, with some resembling responses seen in Parkinson's disease and others in Alzheimer's disease. Further research into the impact of protein misfolded oligomers on the immune system could lead to the development of blood-based diagnostic methods.
Increasing evidence indicates that peripheral immune cells play a prominent role in neurodegeneration connected to protein misfolding, which are associated with formation of aberrant aggregates, including soluble protein misfolded oligomers. The precise links, however, between the physicochemical features of diverse oligomers and their effects on the immune system, particularly on adaptive immunity, remain currently unexplored, due partly to the transient and heterogeneous nature of the oligomers themselves. To overcome these limitations, we took advantage of two stable and well-characterized types of model oligomers (A and B), formed by HypF-N bacterial protein, type B oligomers displaying lower solvent-exposed hydrophobicity. Exposure to oligomers of human peripheral blood mononuclear cells (PBMCs) revealed differential effects, with type B, but not type A, oligomers leading to a reduction in CD4(+) cells. Type A oligomers promoted enhanced differentiation towards CD4(+)CD25(High)FoxP3(+) Tregs and displayed a higher suppressive effect on lymphocyte proliferation than Tregs treated with oligomers B or untreated cells. Moreover, our results reveal Th1 and Th17 lymphocyte differentiation mediated by type A oligomers and a differential balance of TGF-beta, IL-6, IL-23, IFN-gamma and IL-10 mediators. These results indicate that type B oligomers recapitulate some of the biological responses associated with Parkinson's disease in peripheral immunocompetent cells, while type A oligomers resemble responses associated with Alzheimer's disease. We anticipate that further studies characterizing the differential effects of protein misfolded oligomers on the peripheral immune system may lead to the development of blood-based diagnostics, which could report on the type and properties of oligomers present in patients.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available